BioCentury
ARTICLE | Company News

Mati Therapeutics Inc., QLT deal

January 7, 2013 8:00 AM UTC

On Dec. 24, 2012, QLT said it granted Mati an exclusive, 90-day option to acquire assets related to QLT's punctal plug delivery system for $500,000. Mati can extend the option for up to three successive 30-day periods for an additional $100,000 payment per extension. If Mati exercises the option, QLT will receive $750,000 and be eligible for undisclosed milestone payments and a low single-digit royalty on products developed from the technology. ...